Clinical trial
Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes…
NCT00432276 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00432276 |
|---|---|
| Title | Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus |
| Official title | A Multicenter, Randomized, Double-Blind Study to Determine the Efficacy and Safety of the Addition of SYR-322 25 mg Versus Dose Titration From 30 mg to 45 mg of Pioglitazone HCl (ACTOS®) in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Control on a Combination of Metformin and 30 mg of… |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Alogliptin, Pioglitazone, Metformin, Placebo |
| Enrollment | 803 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Feb 7, 2007 |
| Last update posted | Apr 4, 2013 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: